We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAUT icon
676
Nautilus Biotechnolgy
NAUT
$152M
$803K 0.01%
155,000
– –
CF icon
677
CF Industries
CF
$18.9B
$799K 0.01%
11,288
-432
-4% -$27K
CBOE icon
678
Cboe Global Markets
CBOE
$31.1B
$789K 0.01%
6,053
+879
+17% +$113K
DISCK
679
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$782K 0.01%
34,157
+4,753
+16% +$114K
NLY icon
680
Annaly Capital Management
NLY
$17.4B
$779K 0.01%
24,911
– –
PTON icon
681
Peloton Interactive
PTON
$2.84B
$777K 0.01%
21,734
-25,202
-54% -$1.54M
AKYA
682
DELISTED
Akoya BioSciences
AKYA
$770K ﹤0.01%
50,300
+8,000
+19% +$105K
IRM icon
683
Iron Mountain
IRM
$37.4B
$767K ﹤0.01%
14,653
– –
CMA
684
DELISTED
Comerica
CMA
$758K ﹤0.01%
8,711
– –
MGA icon
685
Magna International
MGA
$18.8B
$751K ﹤0.01%
9,269
+186
+2% +$15.1K
BG icon
686
Bunge Global
BG
$22.8B
$747K ﹤0.01%
8,005
-3,869
-33% -$345K
WHR icon
687
Whirlpool
WHR
$2.49B
$746K ﹤0.01%
3,181
-1,022
-24% -$224K
CGNX icon
688
Cognex
CGNX
$10B
$739K ﹤0.01%
9,505
– –
GATX icon
689
GATX Corp
GATX
$6.6B
$735K ﹤0.01%
7,051
-2,924
-29% -$292K
RCI icon
690
Rogers Communications
RCI
$18.8B
$733K ﹤0.01%
15,382
+385
+3% +$18.1K
AEM icon
691
Agnico Eagle Mines
AEM
$71.9B
$692K ﹤0.01%
13,017
+5,035
+63% +$268K
TECK icon
692
Teck Resources
TECK
$28.8B
$692K ﹤0.01%
23,981
-12,691
-35% -$348K
ACGL icon
693
Arch Capital
ACGL
$37.2B
$689K ﹤0.01%
15,491
– –
FNV icon
694
Franco-Nevada
FNV
$40.6B
$687K ﹤0.01%
4,963
-169
-3% -$23.4K
PKG icon
695
Packaging Corp of America
PKG
$22.6B
$681K ﹤0.01%
4,999
-862
-15% -$116K
WYNN icon
696
Wynn Resorts
WYNN
$10.3B
$674K ﹤0.01%
7,920
-894
-10% -$79.2K
NFG icon
697
National Fuel Gas
NFG
$7.73B
$658K ﹤0.01%
10,284
-454
-4% -$27.1K
TAP icon
698
Molson Coors Class B
TAP
$7.97B
$655K ﹤0.01%
14,134
– –
TXG icon
699
10x Genomics
TXG
$5.97B
$646K ﹤0.01%
4,334
– –
ELAN icon
700
Elanco Animal Health
ELAN
$12.7B
$638K ﹤0.01%
22,491
– –
26 27
28
29 30

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.